Ep. 3 - Appropriations Bill, FTC Settlement and TrumpRx Updates: What We Know So Far

Summary

In this 17‑minute episode, Mike and Madison break down three hot federal health‑care topics: the upcoming appropriations bill and its potential impact on pharmacy‑benefit funding, the recent FTC settlement affecting pharmacy benefit managers, and the latest developments surrounding TrumpRx. They explain how the appropriations bill could reshape budget allocations for employer‑sponsored plans, highlight the FTC’s enforcement actions that may increase transparency and competition among PBMs, and assess what the TrumpRx updates mean for drug pricing and access. Their analysis combines regulatory insight with practical implications for plan sponsors, emphasizing steps employers can take to stay compliant and control costs.